Science: Holy Grail of the tropics

Malaria has confounded scientists for decades, but now there may be a vaccine that works.

At the end of a maze of corridors in an anonymous building at Leeds University is a locked door. "It's a little warm in here," says Professor Mike Hollingdale as he leads the way inside. In fact the atmosphere hits you in the face like a hot flannel, causing beads of perspiration spontaneously to erupt across your forehead.

The small, white-walled room is bare save for a sink and a couple of laboratory benches. On one bench is an array of what look like washing- up bowls, each containing a few inches of water. Inside these, swarms of brown larvae dart frantically, or cluster around pellets of dog meal. On the other bench are a pair of cages draped in white mesh. From these comes a familiar, slightly irritating high-pitched whine.

The stuffy, humid room is a mosquito hatchery. It is part of a facility - unique in this country - capable of growing cultures of Plasmodium falciparum - the most important of the four species of the Plasmodium parasite responsible for one of the world's most insidious and devastating diseases, one that kills about three million people each year, mostly children. Professor Hollingdale is on the trail of the Holy Grail of tropical medicine - the development of a malaria vaccine.

The problem of malaria is worsening, and many experts believe that the only realistic solution is the development of a vaccine. But more than two decades of apparent breakthroughs followed by disappointing setbacks have shown that the challenge is far from straightforward.

Part of the difficulty undoubtedly lies in the complex life-cycle of the parasite. P. falciparum is a single-celled organism transmitted by the female mosquito. The form of the organism when it is inside the mosquito is called the sporozoite. When an infected mosquito bites someone, it injects around 100 sporozoites into their blood.

These travel in the bloodstream until they reach the liver. Here, a special protein on the surface of the sporozoite, termed CSP, recognises that it has arrived at the liver and anchors itself to the outside of the cell. The sporozoite then crosses into the liver. Once inside the liver cell, the organism changes shape, from being long and thin to being bloated and spherical. This is termed the schizont stage, and within the schizont thousands of nuclei begin to develop. Eventually maybe 20,000 daughter parasites will form.

These are called merezoites and their sheer volume causes the liver cell to burst open, releasing them into the bloodstream. When a merezoite meets a circulating red blood cell it attaches itself to the surface and enters. Once inside it divides into 15 or 20 daughters in 48 hours. These rupture the blood cell and are released to infect new cells. It is at this stage that the symptoms of malaria appear.

Vaccines work by giving the body's immune system a "preview" of a harmful pathogen - or the relevant bit of it. This allows us to manufacture the appropriate defence hardware rapidly in the event of an invasion by the real thing.

In the early 1970s it was shown that irradiated sporozoites, created by irradiating infected mosquitoes, could confer protection. This, however, is not a feasible way of delivering mass vaccination.

"The experiments with the irradiated sporozoites told us that it is possible to develop a vaccine," says Professor Brian Greenwood, of the London School of Hygiene and Tropical Medicine, who has been involved with vaccine trials in Africa. "The problem is how to devise a simple and practical way of doing it."

In the late Eighties, a putative vaccine was developed by a Colombian scientist, Manual Patarroyo. This consisted of fragments of proteins found on the surface of the parasite artificially stitched together. Early trials suggested that the vaccine produced a high degree of protection, but later studies have cast serious doubt on its effectiveness.

A series of vaccines have been developed based on the CSP. These have given varying degrees of, usually limited, protection. A field trial in The Gambia has just been completed on the latest version of a CSP vaccine, and the results are being analysed. Altogether, says Professor Greenwood, there are about 20 candidate vaccines in development.

The Leeds laboratory is one of the few places in the world able to produce the parasite under conditions which effectively mimic what goes on in sub-Saharan Africa. The parasite is first grown in blood cultures. The infected cultures are then covered by a latex membrane to simulate human skin (condoms were used in early tests). Mosquitoes are allowed to settle on the membrane and take up the parasite. These are then removed from the mosquito's body and transferred to the cultured liver cells.

Under these controlled conditions, scientists can arrest the parasite's life-cycle at any point to scrutinise the biochemical interactions taking place - which genes are active at a given time, or which proteins are essential to a particular series of events. Professor Hollingdale's team is especially interested in a protein called LSA-1. This is a large protein secreted by the parasite as it sits in the liver cells. The protein is an antigen - it elicits an immune response - in other words it stimulates the immune defences to attack it, which makes it a good candidate for a vaccine.

LSA-1 appears to activate one particular aspect of the immune defence, T-cells. These are specialised cells that are produced by the body to seek out and destroy any of the body's cells which are infected by foreign invaders. Professor Hollingdale's team has been working with adult volunteers in Papua New Guinea. By taking samples of blood and adding LSA-1 or specific fragments of the protein, they wanted to see if T-cells were produced by the blood. "Some of the volunteers had previously built up a natural protection to malaria while others had not. The group who were protected had T-cells to LSA-1 in their blood, while the group who were not protected didn't have any. This had never previously been shown and to us strongly implicated that T-cells were important in conferring protection.

"We believe that from these studies and others that there is a strong rationale for producing a vaccine based on LSA-1," says Professor Hollingdale.

The team is looking at a variety of methods to deliver the antigen as a vaccine, and is looking for funding to begin human trials within two years. The European Union has recently earmarked a budget for malaria research and Professor Hollingdale is hoping to help set up a European network to develop a concerted research effort into the development of a vaccine.

"Europe has generated a lot of the candidates for vaccines but has not really had the capital or unity to take these into the complex areas of clinical testing," says Dr David Arnot of Edinburgh University, who has been studying the molecular biology of the malaria parasite for 20 years. "Now we have the opportunity to work in close harness, which I think is an excellent thing. I am reasonably optimistic that within 10 years of good support, and with all the groups pulling hard in a concerted effort, we have a good chance of getting something to work."

Professor Greenwood agrees on the value of a united European approach. "We have been strong on the laboratory side but not had a great presence in testing potential vaccines. Hopefully this EU initiative will go some way to bridging that gap."

As for the prospects for a vaccine, Professor Greenwood remains cautious but optimistic. "For the past 20 years people have been saying `we'll have a vaccine within five years' - and they are still saying it. My own feeling is that we are unlikely to see a dramatic breakthrough, but rather an accumulation of gradual improvements. I think it is right that we follow the diverse approaches that we are pursuing now, and hope that out of this someone will hit upon something that works."

Arts and Entertainment
Peter Griffin holds forth in The Simpsons Family Guy crossover episode

TV
Arts and Entertainment
Pedro Pascal gives a weird look at the camera in the blooper reel

TV
Arts and Entertainment
Public vote: Art Everywhere poster in a bus shelter featuring John Hoyland
artVoted for by the public, artworks on Art Everywhere posters may be the only place where they can be seen
Arts and Entertainment
Judd Apatow’s make-it-up-as-you-go-along approach is ideal for comedies about stoners and slackers slouching towards adulthood
filmWith comedy film audiences shrinking, it’s time to move on
PROMOTED VIDEO
Arts and Entertainment
booksForget the Man Booker longlist, Literary Editor Katy Guest offers her alternative picks
Arts and Entertainment
Off set: Bab El Hara
tvTV series are being filmed outside the country, but the influence of the regime is still being felt
Have you tried new the Independent Digital Edition apps?
Arts and Entertainment
Red Bastard: Where self-realisation is delivered through monstrous clowning and audience interaction
comedy
Arts and Entertainment
O'Shaughnessy pictured at the Unicorn Theatre in London
tvFiona O'Shaughnessy explains where she ends and her strange and wonderful character begins
Arts and Entertainment
The new characters were announced yesterday at San Diego Comic Con

TV
Arts and Entertainment
Rhino Doodle by Jim Carter (Downton Abbey)

TV
Arts and Entertainment
No Devotion's Geoff Rickly and Stuart Richardson
musicReview: No Devotion, O2 Academy Islington, London
Arts and Entertainment
Christian Grey cradles Ana in the Fifty Shades of Grey film

film
Arts and Entertainment
Comedian 'Weird Al' Yankovic

Is the comedy album making a comeback?

comedy
Arts and Entertainment
While many films were released, few managed to match the success of James Bond blockbuster 'Skyfall'
film
Arts and Entertainment
Jamie Dornan as Christian Grey in the first-look Fifty Shades of Grey movie still

film
Arts and Entertainment
Sue Perkins and Mel Giedroyc, centre, are up for Best Female TV Comic for their presenting quips on The Great British Bake Off

TV
Arts and Entertainment
Martin Freeman as Lester Nygaard in the TV adaptation of 'Fargo'

TV
Arts and Entertainment
A scene from Shakespeare in Love at the Noel Coward Theatre
theatreReview: Shakespeare in Love has moments of sheer stage poetry mixed with effervescent fun
Arts and Entertainment
Dwayne 'The Rock' Johnson stars in Hercules

film
Arts and Entertainment
Standing the test of time: Michael J Fox and Christopher Lloyd in 'Back to the Future'

film
Arts and Entertainment
<p><strong>2008</strong></p>
<p>Troubled actor Robert Downey Jr cements his comeback from drug problems by bagging the lead role in Iron Man. Two further films follow</p>

film
Arts and Entertainment

theatre
Arts and Entertainment
Tycoons' text: Warren Buffett and Bill Gates both cite John Brookes' 'Business Adventures' as their favourite book

books
Independent
Travel Shop
the manor
Up to 70% off luxury travel
on city breaks Find out more
santorini
Up to 70% off luxury travel
on chic beach resorts Find out more
sardina foodie
Up to 70% off luxury travel
on country retreats Find out more
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    A new Russian revolution: Cracks start to appear in Putin’s Kremlin power bloc

    A new Russian revolution

    Cracks start to appear in Putin’s Kremlin power bloc
    Eugene de Kock: Apartheid’s sadistic killer that his country cannot forgive

    Apartheid’s sadistic killer that his country cannot forgive

    The debate rages in South Africa over whether Eugene de Kock should ever be released from jail
    Standing my ground: If sitting is bad for your health, what happens when you stay on your feet for a whole month?

    Standing my ground

    If sitting is bad for your health, what happens when you stay on your feet for a whole month?
    Commonwealth Games 2014: Dai Greene prays for chance to rebuild after injury agony

    Greene prays for chance to rebuild after injury agony

    Welsh hurdler was World, European and Commonwealth champion, but then the injuries crept in
    Israel-Gaza conflict: Secret report helps Israelis to hide facts

    Patrick Cockburn: Secret report helps Israel to hide facts

    The slickness of Israel's spokesmen is rooted in directions set down by pollster Frank Luntz
    The man who dared to go on holiday

    The man who dared to go on holiday

    New York's mayor has taken a vacation - in a nation that has still to enforce paid leave, it caused quite a stir, reports Rupert Cornwell
    Best comedians: How the professionals go about their funny business, from Sarah Millican to Marcus Brigstocke

    Best comedians: How the professionals go about their funny business

    For all those wanting to know how stand-ups keep standing, here are some of the best moments
    The Guest List 2014: Forget the Man Booker longlist, Literary Editor Katy Guest offers her alternative picks

    The Guest List 2014

    Forget the Man Booker longlist, Literary Editor Katy Guest offers her alternative picks
    Jokes on Hollywood: 'With comedy film audiences shrinking, it’s time to move on'

    Jokes on Hollywood

    With comedy film audiences shrinking, it’s time to move on
    It's the best of British art... but not all is on display

    It's the best of British art... but not all is on display

    Voted for by the British public, the artworks on Art Everywhere posters may be the only place where they can be seen
    Critic claims 'I was the inspiration for Blanche DuBois'

    Critic claims 'I was the inspiration for Blanche DuBois'

    Blanche Marvin reveals how Tennessee Williams used her name and an off-the-cuff remark to create an iconic character
    Sometimes it's hard to be a literary novelist

    Sometimes it's hard to be a literary novelist

    Websites offering your ebooks for nothing is only the latest disrespect the modern writer is subjected to, says DJ Taylor
    Edinburgh Fringe 2014: The comedy highlights, from Bridget Christie to Jack Dee

    Edinburgh Fringe 2014

    The comedy highlights, from Bridget Christie to Jack Dee
    Dame Jenny Abramsky: 'We have to rethink. If not, museums and parks will close'

    Dame Jenny Abramsky: 'We have to rethink. If not, museums and parks will close'

    The woman stepping down as chair of the Heritage Lottery Fund is worried